OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

Rhea-AI Summary

OPKO Health, Inc. (NASDAQ: OPK) will announce its financial results for the first quarter of 2023 on May 3, 2023, after market close. The company plans to host a conference call and webcast to discuss the results and provide financial guidance at 4:30 p.m. Eastern time on the same day. Interested participants are encouraged to pre-register for the call to receive a unique PIN for immediate access. A replay of the call will be available until May 10, 2023. OPKO is focused on establishing leading positions in biopharmaceuticals and diagnostics through its proprietary technologies and expertise.

MIAMI, April 25, 2023 (GLOBE NEWSWIRE) --  OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2023 after the close of the U.S. financial markets on Wednesday, May 3, 2023. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 3^rd beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available until May 10, 2023 by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 4576780. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com

FAQ

When will OPKO Health report its financial results for Q1 2023?

OPKO Health will report its financial results for the three months ended March 31, 2023, on May 3, 2023, after the close of U.S. financial markets.

What time is OPKO's conference call to discuss Q1 2023 results?

The conference call to discuss OPKO's Q1 2023 results will begin at 4:30 p.m. Eastern time on May 3, 2023.

How can I access OPKO Health's conference call?

Participants can pre-register for OPKO's conference call online or dial in at 833-630-0584 (U.S.) or 412-317-1815 (International) to participate.

Will there be a replay available for OPKO's conference call?

Yes, a telephone replay will be available until May 10, 2023, and a webcast replay will be accessible about one hour after the live call.